2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$18.39-$0.17 (-0.94%)
Price as of Oct 22, 2026 7:55 PM EDT- $2.0BMarket Cap
- -17.40%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$18.39-$0.17 (-0.94%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 17.98% | 19.0M | +4.2M (+22.32%) | Jun 30, 2026 |
VANGUARD GROUP INC | 11.18% | 11.8M | +993,283 (+8.41%) | Dec 31, 2025 |
BLACKROCK FUNDING, INC. /DE | 10.60% | 11.2M | +168,672 (+1.51%) | Dec 31, 2024 |
BLACKROCK INC. | 9.77% | 10.3M | +4.4M (+42.27%) | Jun 30, 2024 |
STATE STREET CORP | 8.44% | 8.9M | +2.3M (+25.83%) | Jun 30, 2026 |
N/A | 7.93% | 8.4M | +1.7M (+20.73%) | Jun 30, 2026 |
VANGUARD PORTFOLIO MANAGEMENT LLC | 7.93% | 8.4M | +1.7M (+20.73%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 7.59% | 8.0M | +34,637 (+0.43%) | Jun 30, 2026 |
FIRST TRUST EXCHANGE-TRADED FUND | 3.39% | 3.6M | +199,056 (+5.55%) | Jun 30, 2026 |
VANGUARD HORIZON FUNDS | 1.32% | 1.4M | +636,398 (+45.58%) | Jun 30, 2026 |
FIDELITY SALEM STREET TRUST | 1.09% | 1.2M | +1.0M (+87.70%) | Jul 31, 2026 |
Federated Hermes Equity Funds | 1.05% | 1.1M | -87,155 (-7.88%) | Jul 31, 2026 |
Tekla Healthcare Opportunities Fund | 0.87% | 921,334 | -39,683 (-4.31%) | Jun 30, 2026 |
TEKLA HEALTHCARE INVESTORS | 0.80% | 844,819 | -96,741 (-11.45%) | Jun 30, 2026 |
Current Ownership Distribution
- Mutual Funds2.1B (56.12%)
- Institutions1.6B (43.28%)
- Insiders22.7M (0.60%)
- Other0 (0.00%)
Insider Transactions
- 0.60% (22.7M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 2Number of InsiderSelling (last 12 months)
- $4.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Rodino-Klapac Louise President, R&D and Tech Ops | In Kind | Sep 04, 2026 | $476,019.06 | 21,423 | $22.22 | 203,900 |
Rothfuss Cristin EVP, General Counsel | In Kind | Sep 04, 2026 | $489,395.50 | 22,025 | $22.22 | 115,519 |
SEVERINO MICHAEL Chief Executive Officer | Award | Jul 28, 2026 | $0.00 | 2.2M | $0.00 | 2.2M |
SEVERINO MICHAEL Chief Executive Officer | Award | Jul 28, 2026 | $0.00 | 756,104 | $0.00 | 756,104 |
Mayo Stephen | Sell | Mar 12, 2026 | $123,207.78 | 7,239 | $17.02 | 1,765 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 11, 2026 | $18,681.91 | 1,097 | $17.03 | 201,983 |
Wong Ryan Ho-Yan Chief Financial Officer | In Kind | Mar 11, 2026 | $4,359.68 | 256 | $17.03 | 135,064 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 11, 2026 | $16,587.22 | 974 | $17.03 | 137,544 |
Rodino-Klapac Louise President, R&D and Tech Ops | In Kind | Mar 09, 2026 | $8,542.80 | 504 | $16.95 | 227,166 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 09, 2026 | $17,560.20 | 1,036 | $16.95 | 203,663 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 09, 2026 | $8,203.80 | 484 | $16.95 | 138,864 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 09, 2026 | $9,881.85 | 583 | $16.95 | 203,080 |
Rodino-Klapac Louise President, R&D and Tech Ops | In Kind | Mar 09, 2026 | $15,170.25 | 895 | $16.95 | 226,271 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 09, 2026 | $5,864.70 | 346 | $16.95 | 138,518 |
Wong Ryan Ho-Yan Chief Financial Officer | In Kind | Mar 02, 2026 | $7,290.00 | 450 | $16.20 | 135,595 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 02, 2026 | $53,476.20 | 3,301 | $16.20 | 205,574 |
Rothfuss Cristin EVP, General Counsel | In Kind | Mar 02, 2026 | $6,609.60 | 408 | $16.20 | 139,348 |
Estepan Ian Michael Chief Operating Officer | In Kind | Mar 02, 2026 | $14,175.00 | 875 | $16.20 | 204,699 |
Estepan Ian Michael Chief Operating Officer | Exempt | Mar 01, 2026 | $0.00 | 8,125 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Exempt | Mar 01, 2026 | $0.00 | 8,125 | $0.00 | 208,875 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $0.00 | 2,069 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $0.00 | 5,381 | $0.00 | 0 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $28,365.99 | 2,069 | $13.71 | 195,369 |
Estepan Ian Michael Chief Operating Officer | Exempt | Feb 26, 2026 | $73,773.51 | 5,381 | $13.71 | 200,750 |
Rodino-Klapac Louise President, R&D and Tech Ops | Award | Feb 25, 2026 | $0.00 | 1,875 | $0.00 | 8,125 |
Estepan Ian Michael Chief Operating Officer | Award | Feb 25, 2026 | $0.00 | 1,875 | $0.00 | 8,125 |
Nicaise Claude | Exempt | Jan 29, 2026 | $0.00 | 10,500 | $0.00 | 0 |
Nicaise Claude | Exempt | Jan 29, 2026 | $143,955.00 | 10,500 | $13.71 | 38,312 |
Nicaise Claude | In Kind | Jan 29, 2026 | $143,939.40 | 6,780 | $21.23 | 31,532 |
Chambers Michael Andrew | Return | Dec 18, 2025 | $0.00 | 0 | $0.00 | 0 |